BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BBMRI-ERIC - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BBMRI-ERIC
X-ORIGINAL-URL:https://dev3.bbmri-eric.eu
X-WR-CALDESC:Events for BBMRI-ERIC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261110T103000
DTEND;TZID=Europe/Vienna:20261110T113000
DTSTAMP:20261008T122016Z
CREATED:20261008T121406Z
LAST-MODIFIED:20261008T122016Z
UID:89049-1794306600-1794310200@dev3.bbmri-eric.eu
SUMMARY:Urine Liquid Biopsy – About Chances and Challenges
DESCRIPTION:Register here!\nThe webinar will take place on 10 November 2026\, 10:30-11:30 CET \nSummary: \nCell-free DNA (cfDNA) analysis is an increasingly important component of liquid biopsy\, enabling non-invasive biomarker research\, disease detection and monitoring. Urine represents an attractive specimen type due to its ease of collection and potential to provide information from both urological and non-urological diseases. However\, urine cfDNA is highly susceptible to preanalytical variables that can affect sample quality\, quantity and analytical reliability. \nThis webinar introduces urine cfDNA and its applications in liquid biopsy\, highlights key challenges associated with specimen collection\, stabilization\, processing\, and cfDNA quality control\, and explains why standardization of the preanalytical workflow is essential. Drawing on the concepts underlying the ISO 18704 standard\, participants will gain practical insights into factors that contribute to reproducible and reliable urine cfDNA analyses. \nSpeaker \nDr. Daniela Mancarella-Langer (QIAGEN) \nHost \nDr. Maike Tauchert \nAfter watching the webinar\, participants will have acquired the following knowledge:\n\nExplain the biological origin of cfDNA and its role in liquid biopsy applications.\nDescribe the opportunities and limitations of urine as a specimen for cfDNA analysis.\nIdentify critical preanalytical variables that influence urine cfDNA quality\, quantity and downstream analytical performance.\nUnderstand the importance of specimen stabilization\, processing\, cfDNA isolation\, quality control\, and documentation to obtain reliable results.
URL:https://dev3.bbmri-eric.eu/events/urine-liquid-biopsy-about-chances-and-challenges/
CATEGORIES:Academy,BBMRI-ERIC,Webinar
ATTACH;FMTTYPE=image/png:https://dev3.bbmri-eric.eu/wp-content/uploads/2026/10/BBMRI.QM-ACADEMY-Urine-Liquid-Biopsy-e1791461905669.png
END:VEVENT
END:VCALENDAR